Gabelli Funds LLC Sells 24,000 Shares of Bausch Health Companies Inc. (NYSE:BHC)

Gabelli Funds LLC lowered its stake in shares of Bausch Health Companies Inc. (NYSE:BHCFree Report) by 26.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 67,000 shares of the company’s stock after selling 24,000 shares during the quarter. Gabelli Funds LLC’s holdings in Bausch Health Companies were worth $537,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in BHC. Principal Securities Inc. bought a new position in Bausch Health Companies during the fourth quarter valued at about $31,000. Tower Research Capital LLC TRC boosted its position in Bausch Health Companies by 283.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,918 shares of the company’s stock worth $55,000 after purchasing an additional 5,112 shares during the period. Bfsg LLC bought a new position in Bausch Health Companies during the fourth quarter worth about $63,000. Jump Financial LLC bought a new position in Bausch Health Companies during the third quarter worth about $92,000. Finally, Mitsubishi UFJ Trust & Banking Corp bought a new position in Bausch Health Companies during the third quarter worth about $103,000. Institutional investors own 78.65% of the company’s stock.

Bausch Health Companies Stock Performance

BHC stock opened at $6.32 on Tuesday. Bausch Health Companies Inc. has a one year low of $6.09 and a one year high of $11.46. The company has a market capitalization of $2.32 billion, a PE ratio of -5.10 and a beta of 0.83. The company’s 50 day moving average price is $7.82 and its two-hundred day moving average price is $8.16.

Bausch Health Companies (NYSE:BHCGet Free Report) last issued its earnings results on Thursday, May 2nd. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.75 by ($0.16). Bausch Health Companies had a negative return on equity of 2,370.91% and a negative net margin of 5.07%. The firm had revenue of $2.15 billion during the quarter, compared to the consensus estimate of $2.18 billion. On average, research analysts predict that Bausch Health Companies Inc. will post 3.63 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Royal Bank of Canada cut their target price on shares of Bausch Health Companies from $12.00 to $11.00 and set a “sector perform” rating for the company in a research report on Tuesday, April 23rd. Jefferies Financial Group lowered their target price on shares of Bausch Health Companies from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, February 20th. Piper Sandler raised their target price on shares of Bausch Health Companies from $7.00 to $9.00 and gave the company a “neutral” rating in a research note on Monday, April 29th. Finally, StockNews.com raised shares of Bausch Health Companies from a “hold” rating to a “buy” rating in a research note on Wednesday, May 15th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $11.33.

Get Our Latest Analysis on BHC

Bausch Health Companies Company Profile

(Free Report)

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

Read More

Want to see what other hedge funds are holding BHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bausch Health Companies Inc. (NYSE:BHCFree Report).

Institutional Ownership by Quarter for Bausch Health Companies (NYSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.